AT1
Showing 1 - 25 of >10,000
ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)
Recruiting
- ANCA Associated Vasculitis
- +2 more
-
Edinburgh, United KingdomCentre for Cardiovascular Science, Queen's Medical Research Inst
Jan 26, 2023
Obstructive Sleep Apnea Syndrome in Type 1 Diabetic Patients
Enrolling by invitation
- Type 1 Diabetes
- Diagnosis of sleep apnea by oxymetry
-
Grenoble, Isère, FranceUniversity Hospital Grenoble
Jan 3, 2023
Hernia, Ventral, Intestinal Fistula, Fibromatosis, Abdominal Trial in Columbus (procedure, other, device)
Recruiting
- Hernia, Ventral
- +2 more
- Abdominal wall reconstruction with Strattice
- +19 more
-
Columbus, OhioThe Ohio State University Wexner Medical Center
Sep 21, 2022
Cigarette Smoking, Nicotine Vaping Trial in Roanoke (All nicotine/ tobacco products at market price, Nicotine vaping products at
Recruiting
- Cigarette Smoking
- Nicotine Vaping
- All nicotine/ tobacco products at market price
- +6 more
-
Roanoke, VirginiaFralin Biomedical Research Institute
Jul 7, 2022
Covid19 Trial in Cypress (VXA-CoV2-1)
Completed
- Covid19
- VXA-CoV2-1
-
Cypress, CaliforniaWCCT
Jan 17, 2023
The Predictive Capacity of Peripheral Muscle Function on Quality
Recruiting
- Obesity
-
Férolles-Attilly, FranceHôpital Forcilles
Jul 28, 2022
Cardiorenal Syndrome (CRS) Trial in Rochester (Candesartan, Placebo)
Completed
- Cardiorenal Syndrome (CRS)
- Candesartan
- Placebo
-
Rochester, MinnesotaMayo Clinic
Oct 20, 2021
Periapical Diseases Trial in Van (Er,Cr:YSSG laser, Control)
Active, not recruiting
- Periapical Diseases
- Er,Cr:YSSG laser
- Control
-
Van, TurkeyYuzuncu Yıl University
Jul 28, 2022
Pain Trial in Brooklyn (Nebulized Sub-dissociative Dose Ketamine at either 0.75 mg/kg, Nebulized Sub-dissociative Dose Ketamine
Recruiting
- Pain
- Nebulized Sub-dissociative Dose Ketamine at either 0.75 mg/kg
- +2 more
-
Brooklyn, New YorkMaimonides Medical Center
Apr 7, 2022
Diabetic Gastroparesis Trial in Augusta (2400 ThorS-MagNT Stimulations at 1Hz, 2400 ThorS-MagNT Stimulations at 10Hz, Sham
Recruiting
- Diabetic Gastroparesis
- 2400 ThorS-MagNT Stimulations at 1Hz
- +2 more
-
Augusta, GeorgiaAugusta University
Jun 29, 2022
Labor Dystocia, Labor Complication, Labor Onset and Length Abnormalities Trial in Greåker (the labour care guide (LCG))
Not yet recruiting
- Labor Dystocia
- +7 more
- the labour care guide (LCG)
-
Greåker, Ostfold, NorwayOstfold Hospital Trust
Mar 17, 2023
Description of Immunologic, Enzymatic and Metabolic Biomarkers
Recruiting
- Covid19
- Blood collection at Day 8, Day 16, Day 24, Month 6 and Month 12 after first symptoms from SARS-CoV-2 infection.
- Blood collection at 1st injection of vaccine against COVID-19, at at second injection of vaccine, at Month 1, Month 2, Month 6 and Month 12 after second injection of vaccine for volunteers
-
Poitiers, FranceC.H.U.de Poitiers
Jun 22, 2022
Iron Hepatic Overload, Fat Hepatic Overload Trial in Lille, Rennes (1,5 Tesla abdominal MRI, 3 Tesla abdominal MRI)
Completed
- Iron Hepatic Overload
- Fat Hepatic Overload
- 1,5 Tesla abdominal MRI
- 3 Tesla abdominal MRI
-
Lille, France
- +1 more
Feb 14, 2022
Performance Evaluation of a 3D PSIR Sequence in MRI at 1.5T
Recruiting
- Multiple Sclerosis
- MRI 1.5 tesla
-
Bordeaux, France
- +5 more
Mar 18, 2022
SIRT1(rs7069102 ) Gene Polymorphism in Chronic Obstructive
Recruiting
- Genotyping of SIRT1in Chronic Obstructive Pulmonary Disease
- genotyping of SIRT1 in chronic obstructive patients
-
Sohag, EgyptSohag university Hospital
Sep 20, 2023
Hypoxemic Respiratory Failure Trial in Chicago, Barcelona (HFNC flow set at patient peak tidal inspiratory flow, HFNC flow set
Recruiting
- Hypoxemic Respiratory Failure
- HFNC flow set at patient peak tidal inspiratory flow
- +3 more
-
Chicago, Illinois
- +1 more
May 2, 2022
Acute-On-Chronic Liver Failure Trial in Beijing (standard medical treatment, hUC-MSC at week0, Placebo at week0)
Not yet recruiting
- Acute-On-Chronic Liver Failure
- standard medical treatment
- +10 more
-
Beijing, Beijing, Chinathe Fifth Medical Center, Chinese PLA General Hospital
Aug 15, 2023
Physical Fitness Trial in Wuhan (PAP induced at an intensity of 70% 1RM combined with complex training, PAP induced at an
Recruiting
- Physical Fitness
- PAP induced at an intensity of 70% 1RM combined with complex training
- +3 more
-
Wuhan, Hubei, ChinaWuhan Sports University
Oct 8, 2023
Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))
Not yet recruiting
- Muscarinic Receptor Occupancy
- Scopolamine
- [11C]EMO ([11C]LSN3172176)
-
New Haven, ConnecticutYale University
Aug 31, 2023
Type 1 Diabetes Trial (FAM intervention consisting of a Follower of glucose data, Action Plan, and Remote Monitoring of glucose
Not yet recruiting
- Type 1 Diabetes
- FAM intervention consisting of a Follower of glucose data, Action Plan, and Remote Monitoring of glucose data
- standard of care
- (no location specified)
Oct 29, 2023
Discovery of New Cancer in 1-year Follow-up After Ischemic
Recruiting
- Cancer-related Stroke
- +5 more
-
Lausanne, Vaud, Switzerland
- +2 more
Oct 19, 2023
Nutritional Requirements Trial in Columbus (Zero hard-boiled egg at 0 h, One hard-boiled egg at 0 h, Two hard-boiled eggs at 0
Recruiting
- Nutritional Requirements
- Zero hard-boiled egg at 0 h
- +5 more
-
Columbus, OhioOhio State University
Dec 16, 2022
Nasopharyngeal Carcinoma Trial in Guangzhou (BL-B01D1, capecitabine, gemcitabine)
Not yet recruiting
- Nasopharyngeal Carcinoma
- BL-B01D1
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Oct 31, 2023
Mental Health Wellness 1 Trial (Learning to BREATHE)
Not yet recruiting
- Mental Health Wellness 1
- Learning to BREATHE
- (no location specified)
Feb 27, 2023
HIV, HIV Pre-exposure Prophylaxis Trial (MK-8527, Placebo to MK-8527)
Not yet recruiting
- HIV
- HIV Pre-exposure Prophylaxis
- MK-8527
- Placebo to MK-8527
- (no location specified)
Sep 21, 2023